Switzerland's pharmaceutical and medtech sector generates some of the world's most sophisticated M&A transactions. Your operational experience inside these organisations is what separates a credible advisor from a generic one.

ONEtoONE is a global network of 120+ independent M&A advisors in 55 countries. Our Senior Industry Advisors in Switzerland co-advise on transactions where sector precision and executive-level relationships are the defining factors — particularly in pharma, specialty pharma, medtech, and diagnostics.

What you get

• Competitive revenue share on mandates you originate or where your sector expertise drives the process
• Active Swiss and DACH healthcare deal flow: pharma, specialty chemicals, medtech, diagnostics, CROs
• Institutional brand: operate as a Senior Advisor of a recognised global investment banking platform
• 200+ advisors in 55 countries — connecting Swiss healthcare companies with global strateg...